Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 917356, 7 pages
http://dx.doi.org/10.1155/2010/917356
Clinical Study

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver

1Section of Oncology-Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA
2Department of Internal Medicine, Creighton University, Omaha, NE 68131, USA

Received 27 March 2010; Revised 12 June 2010; Accepted 14 July 2010

Academic Editor: Jörg Kleeff

Copyright © 2010 Jue Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [27 citations]

The following is the list of published articles that have cited the current article.

  • Heejei Yoon, Hee Jin Kim, Hyunki Kim, Hanna Lee, Kwon Tae You, Young Nyun Park, and Hoguen Kim, “Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer,” Tohoku Journal of Experimental Medicine, vol. 224, no. 1, pp. 41–46, 2011. View at Publisher · View at Google Scholar
  • Shun-ichi Ariizumi, Yoshihito Kotera, Satoshi Katagiri, Masayuki Nakano, and Masakazu Yamamoto, “Combined Hepatocellular-Cholangiocarcinoma Had Poor Outcomes after Hepatectomy Regardless of Allen and Lisa Class or the Predominance of Intrahepatic Cholangiocarcinoma Cells within the Tumor,” Annals Of Surgical Oncology, vol. 19, no. 5, pp. 1628–1636, 2012. View at Publisher · View at Google Scholar
  • Chern-Horng Lee, Sen-Yung Hsieh, Chee-Jen Chang, and Yu-Jr Lin, “Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 122–127, 2012. View at Publisher · View at Google Scholar
  • Rafael O.P. De Campos, Richard C. Semelka, Rafael M. Azevedo, Miguel Ramalho, Vasco Heredia, Diane M. Armao, and John T. Woosley, “Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients,” Journal of Magnetic Resonance Imaging, vol. 36, no. 5, pp. 1139–1147, 2012. View at Publisher · View at Google Scholar
  • Ying-Bo Li, Jian-Li Gao, Zhang-Feng Zhong, Pui-Man Hoi, Simon Ming-Yuen Lee, and Yi-Tao Wang, “Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways,” Pharmacological Reports, vol. 65, no. 3, pp. 700–709, 2013. View at Publisher · View at Google Scholar
  • Ryan T. Groeschl, Kiran K. Turaga, and T. Clark Gamblin, “Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma,” Journal of Surgical Oncology, vol. 107, no. 6, pp. 608–612, 2013. View at Publisher · View at Google Scholar
  • Song, Lee, Joh, Moon, Lee, Kim, Shin, Kim, Park, Kwon, and Kim, “Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma,” Transplantation Proceedings, vol. 45, no. 8, pp. 3041–3046, 2013. View at Publisher · View at Google Scholar
  • Suresh Maximin, Dhakshina Moorthy Ganeshan, Alampady K. Shanbhogue, Manjiri K. Dighe, Matthew M. Yeh, Orpheus Kolokythas, Puneet Bhargava, and Neeraj Lalwani, “Current update on combined hepatocellular-cholangiocarcinoma,” European Journal of Radiology Open, 2014. View at Publisher · View at Google Scholar
  • Seung Duk Lee, Sang-Jae Park, Sung-Sik Han, Seong Hoon Kim, Young-Kyu Kim, Soon-Ae Lee, Young Hwan Ko, and Eun Kyung Hong, “Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery,” Hepatobiliary & Pancreatic Diseases International, vol. 13, no. 6, pp. 594–601, 2014. View at Publisher · View at Google Scholar
  • Anup S. Shetty, Kathryn J. Fowler, Elizabeth M. Brunt, Saurabh Agarwal, Vamsi R. Narra, and Christine O. Menias, “Combined hepatocellular-cholangiocarcinoma: What the radiologist needs to know about biphenotypic liver carcinoma,” Abdominal Imaging, vol. 39, no. 2, pp. 310–322, 2014. View at Publisher · View at Google Scholar
  • Sharon M. Weber, Dario Ribero, Eileen M. O'Reilly, Norihiro Kokudo, Masaru Miyazaki, and Timothy M. Pawlik, “Intrahepatic Cholangiocarcinoma: expert consensus statement,” Hpb, vol. 17, no. 8, pp. 669–680, 2015. View at Publisher · View at Google Scholar
  • Kathryn Fowler, Nael E. Saad, Elizabeth Brunt, M. B. Majella Doyle, Manik Amin, Neeta Vachharajani, Benjamin Tan, and William C. Chapman, “Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy,” Annals Of Surgical Oncology, vol. 22, no. 13, pp. 4130–4137, 2015. View at Publisher · View at Google Scholar
  • Manik Amin, Benjamin Tan, Amy Zhou, Kathryn J. Fowler, Elizabeth M. Brunt, and Jesse Keller, “Complete response to erlotinib and bevacizumab in a patient with Biphenotypic (hepatobiliary) primary liver carcinoma,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 12, pp. 1468–1473, 2015. View at Publisher · View at Google Scholar
  • Yuki Tanaka, Shinichi Aishima, Kenichi Kohashi, Yukihiko Okumura, Huanlin Wang, Tomoyuki Hida, Kazuhiro Kotoh, Ken Shirabe, Yoshihiko Maehara, Ryoichi Takayanagi, and Yoshinao Oda, “Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma,” Histopathology, 2015. View at Publisher · View at Google Scholar
  • Adam B. Elfant, Thomas A. Judge, Sachin Mohan, Navjot Grewal, and Shaffer R.S. Mok, “A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma,” Journal of Gastrointestinal Oncology, vol. 7, no. 4, pp. 570–579, 2016. View at Publisher · View at Google Scholar
  • Hao Wu, Yan Liu, Xiao-Wei Jiang, Wen-Fang Li, Gang Guo, Jian-Ping Gong, and Xiong Ding, “Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma,” Tumor Biology, 2016. View at Publisher · View at Google Scholar
  • Abhijit Sunnapwar, Rashmi Katre, Maria Policarpio-Nicolas, Venkata Katabathina, and Marc Erian, “Imaging of Rare Primary Malignant Hepatic Tumors in Adults With Histopathological Correlation,” Journal Of Computer Assisted Tomography, vol. 40, no. 3, pp. 452–462, 2016. View at Publisher · View at Google Scholar
  • Sabine Irtan, Louise Barbier, Claire Francoz, Federica Dondero, Francois Durand, and Jacques Belghiti, “Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?,” Hepatobiliary & Pancreatic Diseases International, vol. 15, no. 2, pp. 147–151, 2016. View at Publisher · View at Google Scholar
  • Rory L. Smoot, Ryan T. Groeschl, Tommy Ivanics, Christopher R. Shubert, Michael L. Kendrick, David M. Nagorney, Mark J. Truty, John R. Bergquist, Elizabeth B. Habermann, and Michael B. Farnell, “Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics,” Hpb, vol. 18, no. 11, pp. 886–892, 2016. View at Publisher · View at Google Scholar
  • Arthur Zimmermann, and Arthur Zimmermann, “Combined Hepatocellular-Cholangiocarcinoma,” Tumors and Tumor-Like Lesions of the Hepatobiliary Tract, pp. 481–497, 2016. View at Publisher · View at Google Scholar
  • Calvin T. Sung, Anup Shetty, Christine O. Menias, Roozbeh Houshyar, Shreya Chatterjee, Thomas K. Lee, Paul Tung, Mohammed Helmy, and Chandana Lall, “Collision and composite tumors; radiologic and pathologic correlation,” Abdominal Radiology, 2017. View at Publisher · View at Google Scholar
  • Éric Frampas, Tamara Matysiak-Budnik, Jean-François Mosnier, Yann Touchefeu, and Mäeva Salimon, “Hepatocholangiocarcinoma: A rare tumor to know!,” Hepato-Gastro et Oncologie Digestive, vol. 24, no. 5, pp. 436–444, 2017. View at Publisher · View at Google Scholar
  • Lauren S. Chan, Daniel Y. Sze, George A. Poultsides, John D. Louie, Mohammed A. Abdelrazek Mohammed, and David S. Wang, “Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma,” CardioVascular and Interventional Radiology, 2017. View at Publisher · View at Google Scholar
  • J. Ye, X. Xie, Y. Lin, B. Liu, W. Wang, X. Huang, and G. Huang, “Imaging features of combined hepatocellular–cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings,” Clinical Radiology, 2017. View at Publisher · View at Google Scholar
  • Jieyi Ye, Xiaoyan Xie, Xiaoer Zhang, Wei Wang, Xiaowen Huang, Guangliang Huang, Baoxian Liu, and Mingde Lu, “Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular–Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma,” Ultrasound in Medicine and Biology, vol. 43, no. 11, pp. 2530–2536, 2017. View at Publisher · View at Google Scholar
  • Sung Yong Han, Geun Am Song, Dong Uk Kim, Dong Hoon Baek, Moon Won Lee, and Gwang Ha Kim, “Bile Duct Patency Maintained after Intraductal Radiofrequency Ablation in a Case of Hepatocellular Cholangiocarcinoma with Bile Duct Invasion,” Clinical Endoscopy, vol. 51, no. 2, pp. 201–205, 2018. View at Publisher · View at Google Scholar
  • Maëva Salimon, Thierry Lecomte, Yann Touchefeu, David Tougeron, Morgane Caulet, Jérôme Gournay, Caroline Prieux-Klotz, Jaafar Bennouna, Aziz Zaanan, Manuela Tiako Meyo, Vincent Hautefeuille, and Tamara Matysiak-Budnik, “Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: An AGEO French multicentre retrospective study,” British Journal of Cancer, vol. 118, no. 3, pp. 325–330, 2018. View at Publisher · View at Google Scholar